Figure 4From: Upregulated expression of Annexin II is a prognostic marker for patients with gastric cancerKaplan-Meier curves with univariate analyses (log-rank) for patients with simultaneously low annexin II and S100A6 expression versus high annexin II and S100A6 expression tumors in all gastric cancer. The cumulative five-year survival rates of patients with a simultaneously high expression of annexin II and S100A6 were significantly lower than those in patients with simultaneously low expression (12.7% versus 38.3%, P = 0.000).Back to article page